Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000078222

Meso Scale Discovery R-PLEX Human GCPII/PSMA ASY
SDP

Catalog No. 5000078222
Encompass

The R-PLEX Human GCPII (PSMA) Assay is a multiplex immunoassay panel that measures GCPII (PSMA) in human serum plasma and cell culture supernatants It utilizes Meso Scale Discovery electrochemiluminescence detection technology and provides high sensitivity up to 5 logs of dynamic range and low sample volume requirements The assay measures total GCPII and includes reagents for 100 tests in one sector (5-plex) of an R-PLEX plate GCPII also known as PSMA is highly expressed in prostate tissues and can serve as a biomarker for prostate cancer progression This assay allows sensitive and reproducible quantification of GCPII levels

Catalog No. 50-000-78222 Supplier Meso Scale Discovery Supplier No. K151ABPR2
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

The R-PLEX Human GCPII (PSMA) Assay is a multiplex immunoassay panel that measures GCPII (PSMA) in human serum plasma and cell culture supernatants It utilizes Meso Scale Discovery electrochemiluminescence detection technology and provides high sensitivity up to 5 logs of dynamic range and low sample volume requirements The assay measures total GCPII and includes reagents for 100 tests in one sector (5-plex) of an R-PLEX plate GCPII also known as PSMA is highly expressed in prostate tissues and can serve as a biomarker for prostate cancer progression This assay allows sensitive and reproducible quantification of GCPII levels

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.